Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

Delayed Quote. Delayed  - 07/26 10:00:32 pm
43.6 USD   +0.44%
07/20DJABBOTT LABORATO : Results, Helped by Product Launches, Top Views
07/20 ABBOTT LABORATO : CEO remains noncommittal on Alere deal
07/20DJSt. Jude Medical Logs Double-Digit Sales Growth -- Update
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 Analysis summary4-Traders Strategies 
Strengths
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • The group usually releases upbeat results with huge surprise rates.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at USD 46.01.
  • The stock is close to a major daily resistance at USD 44.08, which should be gotten rid of so as to gain new appreciation potential.
  • The company's enterprise value to sales, at 3.18 times its current sales, is high.
  • The RSI reflects an overbought situation that indicates a possible downturn.
Ratings chart
Subsector Pharmaceuticals - NEC
1st jan.Capitalisation (M$)Investor Rating
ABBOTT LABORATORIES-3.34%63 776
JOHNSON & JOHNSON21.58%343 528
PFIZER INC.13.94%223 065
NOVARTIS AG-5.13%218 815
ROCHE HOLDING LTD.-9.62%217 668
MERCK & CO., INC.10.87%162 096
BRISTOL-MYERS SQUIBB CO9.84%126 133
NOVO NORDISK A/S-6.23%110 385
SANOFI-2.66%108 444
GLAXOSMITHKLINE PLC20.68%105 867
ALLERGAN PLC-20.69%98 039
Autres valeurs du secteur
Advertisement
Financials ($)
Sales 2016 20 915 M
EBIT 2016 4 086 M
Net income 2016 2 377 M
Debt 2016 2 655 M
Yield 2016 2,40%
P/E ratio 2016 23,73
P/E ratio 2017 18,87
EV / Sales 2016 3,18x
EV / Sales 2017 3,03x
Capitalization 63 776 M
More Financials
Chart ABBOTT LABORATORIES
Duration : Period : Day
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | 4-Traders
Duration : Period : Week
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | 4-Traders
Surperformance© ratings  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
More Ratings